Moreover, in diabetes, since the NF-κB pathway serves as a potential target, clinical trials to test for the efficacy of salsalate in reducing glycemia and insulin resistance diabetes were undertaken successfully [115]. This evidence concerns the gene NFKB1 and diabetes mellitus.